Skip to main content
Watch Insiders
Market intelligence
TRAWSector not reported

Traws Pharma, Inc. insider activity

In the last 90 days, 2 corporate insiders purchased $1,996,415 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$1,996,415
Corporate buyers
2
Latest transaction
Apr 16, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Apr 16, 2026Orbimed Advisors LlcCorporate insiderOpen Market Purchase597,729$1.67$998,207
Apr 16, 2026OrbiMed Capital Gp Viii LlcCorporate insiderOpen Market Purchase597,729$1.67$998,207